Loading...
Loading...
Below are the top biotechnology stocks on the NASDAQ in terms of operating margin.
The trailing-twelve-month operating margin at
PDL BioPharma, Inc.PDLI is 94.00%. PDL BioPharma's PEG ratio is 0.28.
The trailing-twelve-month operating margin at
Enzon Pharmaceuticals Inc. ENZN is 92.30%. Enzon Pharmaceuticals' EPS for the same period is $0.65.
The trailing-twelve-month operating margin at
Enanta Pharmaceuticals, Inc. ENTA is 76.20%. Enanta Pharmaceuticals' revenue for the same period is $124.30 million.
The trailing-twelve-month operating margin at
NewLink Genetics Corporation NLNK is 68.10%. NewLink Genetics' EPS growth forecast for the next year is 4.40%.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in